It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
To understand the potential effects of cancer cells on surrounding normal mammary epithelial cells, we performed direct co-culture of non-tumorigenic mammary epithelial MCF10A cells and various breast cancer cells. Firstly, we observed dynamic cell–cell interactions between the MCF10A cells and breast cancer cells including lamellipodia or nanotube-like contacts and transfer of extracellular vesicles. Co-cultured MCF10A cells exhibited features of epithelial-mesenchymal transition, and showed increased capacity of cell proliferation, migration, colony formation, and 3-dimensional sphere formation. Direct co-culture showed most distinct phenotype changes in MCF10A cells followed by conditioned media treatment and indirect co-culture. Transcriptome analysis and phosphor-protein array suggested that several cancer-related pathways are significantly dysregulated in MCF10A cells after the direct co-culture with breast cancer cells. S100A8 and S100A9 showed distinct up-regulation in the co-cultured MCF10A cells and their microenvironmental upregulation was also observed in the orthotropic xenograft of syngeneic mouse mammary tumors. When S100A8/A9 overexpression was induced in MCF10A cells, the cells showed phenotypic features of directly co-cultured MCF10A cells in terms of in vitro cell behaviors and signaling activities suggesting a S100A8/A9-mediated transition program in non-tumorigenic epithelial cells. This study suggests the possibility of dynamic cell–cell interactions between non-tumorigenic mammary epithelial cells and breast cancer cells that could lead to a substantial transition in molecular and functional characteristics of mammary epithelial cells.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Seoul National University College of Medicine, Interdisciplinary Graduate Program in Cancer Biology, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
2 Biomedical Research Institute, Seoul National University Hospital, Center for Medical Innovation, Seoul, Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X)
3 Biomedical Research Institute, Seoul National University Hospital, Center for Medical Innovation, Seoul, Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X); Seoul National University College of Medicine, Department of Surgery, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
4 Seoul National University College of Medicine, Department of Biomedical Sciences, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
5 Seoul National University, Medicinal Bioconvergence Research Center, Suwon, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
6 Genomic Medicine Institute, Seoul National University College of Medicine, Medical Research Center, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University College of Medicine, Department of Biochemistry, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
7 Biomedical Research Institute, Seoul National University Hospital, Center for Medical Innovation, Seoul, Korea (GRID:grid.412484.f) (ISNI:0000 0001 0302 820X); Seoul National University College of Medicine, Department of Surgery, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Genomic Medicine Institute, Seoul National University College of Medicine, Medical Research Center, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)